ArticleHepatobiliary surgery and nutrition2024

Resmetirom for metabolic dysfunction-associated steatohepatitis: targeting hepatic and cardiovascular disease.

Isabella Lurje et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.